Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Irwin

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 19, 2014
Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertensionEva Nozik-Grayck, Crystal Woods, Joann M Taylor, et al.
Cardiovascular and Interventional Radiology|March 18, 2026
Percutaneous Cryoablation of Clinical T1b Renal Tumors: A Tertiary Cancer Center ExperienceMohamed E Abdelsalam, Ahmed Awad, Francis Kang, et al.
Wilderness & Environmental Medicine|July 18, 2015
The Effects of Sympathetic Inhibition on Metabolic and Cardiopulmonary Responses to Exercise in Hypoxic ConditionsRebecca L Scalzo, Garrett L Peltonen, Scott E Binns, et al.
British Journal of Haematology|April 25, 2007
Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myelomaPaul G Richardson, Pieter Sonneveld, Michael W Schuster, et al.
British Journal of Haematology|November 19, 2009
Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myelomaWilliam I Bensinger, Sundar Jagannath, Robert Vescio, et al.
Parkinsonism & Related Disorders|August 19, 2022
Natural speech markers of Alzheimer's disease co-pathology in Lewy body dementiasSanjana Shellikeri, Sunghye Cho, Katheryn A Q Cousins, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 4, 2021
Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson DiseaseWhitley W Aamodt, Teresa Waligorska, Junchao Shen, et al.
Blood|May 28, 2009
Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myelomaPaul Richardson, Sundar Jagannath, Mohamad Hussein, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
Macrophage Xanthine Oxidoreductase Links LPS Induced Lung Inflammatory Injury to NLRP3 Inflammasome Expression and Mitochondrial RespirationMehdi A Fini, Jenifer A Monks, Min Li, et al.
Alzheimer'S Research & Therapy|November 11, 2017
Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseasesKira S Sheinerman, Jon B Toledo, Vladimir G Tsivinsky, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 19, 2014
Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertensionEva Nozik-Grayck, Crystal Woods, Joann M Taylor, et al.
Cardiovascular and Interventional Radiology|March 18, 2026
Percutaneous Cryoablation of Clinical T1b Renal Tumors: A Tertiary Cancer Center ExperienceMohamed E Abdelsalam, Ahmed Awad, Francis Kang, et al.
Wilderness & Environmental Medicine|July 18, 2015
The Effects of Sympathetic Inhibition on Metabolic and Cardiopulmonary Responses to Exercise in Hypoxic ConditionsRebecca L Scalzo, Garrett L Peltonen, Scott E Binns, et al.
British Journal of Haematology|April 25, 2007
Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myelomaPaul G Richardson, Pieter Sonneveld, Michael W Schuster, et al.
British Journal of Haematology|November 19, 2009
Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myelomaWilliam I Bensinger, Sundar Jagannath, Robert Vescio, et al.
Parkinsonism & Related Disorders|August 19, 2022
Natural speech markers of Alzheimer's disease co-pathology in Lewy body dementiasSanjana Shellikeri, Sunghye Cho, Katheryn A Q Cousins, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 4, 2021
Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson DiseaseWhitley W Aamodt, Teresa Waligorska, Junchao Shen, et al.
Blood|May 28, 2009
Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myelomaPaul Richardson, Sundar Jagannath, Mohamad Hussein, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
Macrophage Xanthine Oxidoreductase Links LPS Induced Lung Inflammatory Injury to NLRP3 Inflammasome Expression and Mitochondrial RespirationMehdi A Fini, Jenifer A Monks, Min Li, et al.
Alzheimer'S Research & Therapy|November 11, 2017
Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseasesKira S Sheinerman, Jon B Toledo, Vladimir G Tsivinsky, et al.
Pageof 10